Pertussis-induced cough

Kay Wang1, Anthony Harnden

  • 1Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Roosevelt Drive, Headington, Oxford, OX3 7LF, United Kingdom.

Insights

Despite high vaccination rates, pertussis (whooping cough) remains common due to waning immunity. Diagnosis relies on symptoms like coughing and vomiting, with limited treatment options available for persistent cough.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Pertussis (whooping cough) is a vaccine-preventable disease with high UK vaccination coverage.
  • Waning immunity from pertussis vaccines necessitates understanding persistent infections.
  • Pertussis is frequently observed in individuals with persistent coughs.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and treatment of pertussis.
  • To highlight challenges in pertussis diagnosis and management.
  • To identify areas for future research in pertussis control.

Main Methods:

  • Literature review of pertussis epidemiology and clinical presentation.
  • Analysis of diagnostic indicators including paroxysmal coughing, vomiting, and whooping.
  • Evaluation of diagnostic methods such as culture, PCR, and serology.
  • Review of current treatment strategies and their efficacy.

Main Results:

  • Pertussis diagnosis is challenging, with paroxysmal coughing being sensitive but not specific.
  • Vomiting and whooping are stronger indicators of pertussis.
  • Cough duration varies significantly between children and adults.
  • Current treatments do not resolve pertussis-induced cough, only reducing infectious periods.

Conclusions:

  • Pertussis remains a significant public health concern despite vaccination.
  • Effective treatments for pertussis-induced cough are lacking.
  • Further research is crucial for understanding pertussis epidemiology, improving treatments, and developing better diagnostic tools.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...